, the company had cost of sale of 110.03 million bath compare to 78.13 million baht last year with the increasing of 31.90 million bath or 41% increased, while sale revenue only increase by 33.00% results

net profit in Q2/2019 of 28.2 MB with decrease of 7.0 MB or 20.1 percent, when compared to Q2/2018 (net profit in Q2/2019 of 35.3 MB) as following results:  Revenue The Company and its subsidiaries had

ที่ FPI Ref. FPI.006/2019 14 August 2019 Subject : Management Discussion & Analysis of Performance Results of Quarter 2/2019 To : Board of Directors and President of The Stock Exchange of Thailand

- Translation - 14 August 2019 Subject: Management’s Discussion and Analysis for the Operating Results of the Second Quarter of 2019 Attention: The President of the Stock Exchange of Thailand Exotic

ที่ FPI Ref. FPI.007/2019 14 August 2019 Subject : Management Discussion & Analysis of Performance Results of Quarter 2/2019 (edit) To : Board of Directors and President of The Stock Exchange of

1/4 August 28, 2019 Re: Clarification of the operating results of company and its subsidiaries for the year ended December 31, 2017 To: Boards and Managements The Stock Exchange of Thailand K.C

/2561 June 19, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q1/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited

Ocean Commerce Limited ( Company) No. 4/2018 held on August 8, 2018 , has approved the financial statements and results of operations of the Company. For the ended June 30, 2018 which was audited by the

- Translation - 9 August 2018 Subject: Management’s Discussion and Analysis for the Operating Results of the Second Quarter of 2018 Attention: The President of the Stock Exchange of Thailand Exotic

/2561 August 7, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q2/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited